EP 1515728 A2 20050323 - USE OF ORALLY-AVAILABLE PROSTACYCLIN DERIVATIVES FOR THE PRODUCTION OF A MEDICAMENT FOR THE TREATMENT OF DISEASE STATES ASSOCIATED WITH BONE MARROW OEDEMA
Title (en)
USE OF ORALLY-AVAILABLE PROSTACYCLIN DERIVATIVES FOR THE PRODUCTION OF A MEDICAMENT FOR THE TREATMENT OF DISEASE STATES ASSOCIATED WITH BONE MARROW OEDEMA
Title (de)
VERWENDUNG VON ORAL VERFÜGBAREN PROSTAZYKLINDERIVATEN FÜR DIE HERSTELLUNG EINES ARZNEIMITTELS ZUR BEHANDLUNG VON KRANKHEITEN, DIE MIT KNOCHENMARKÖDEMEN ASSOZIIERT SIND
Title (fr)
UTILISATION DE DERIVES DE PROSTACYCLINE DISPONIBLES PAR VOIE ORALE POUR PREPARER UN PRODUIT PHARMACEUTIQUE POUR TRAITER DES MALADIES QUI SONT ASSOCIEES A DES OEDEMES DE LA MOELLE EPINIERE
Publication
Application
Priority
- DE 10225551 A 20020606
- EP 0305990 W 20030605
Abstract (en)
[origin: WO03103681A2] The invention relates to the use of orally-available prostacyclin derivatives for the production of a medicament for the treatment of disease states associated with bone marrow oedema.
IPC 1-7
IPC 8 full level
A61K 47/40 (2006.01); A61K 31/5578 (2006.01); A61K 31/5585 (2006.01); A61P 19/02 (2006.01); A61P 19/08 (2006.01)
CPC (source: EP KR)
A61K 31/5585 (2013.01 - EP KR); A61P 19/02 (2017.12 - EP); A61P 19/08 (2017.12 - EP)
Citation (search report)
See references of WO 03103681A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 03103681 A2 20031218; WO 03103681 A3 20040325; AU 2003236715 A1 20031222; CA 2488861 A1 20031218; CN 1658882 A 20050824; DE 10225551 A1 20031224; EP 1515728 A2 20050323; JP 2005536476 A 20051202; KR 20050007591 A 20050119; ZA 200500097 B 20060628
DOCDB simple family (application)
EP 0305990 W 20030605; AU 2003236715 A 20030605; CA 2488861 A 20030605; CN 03812976 A 20030605; DE 10225551 A 20020606; EP 03735573 A 20030605; JP 2004510800 A 20030605; KR 20047019813 A 20030605; ZA 200500097 A 20050105